Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease

Neuroscience Letters

Volumn 326, Issue 3, 2002, Pages 155-158

  McNaught, Kevin St P ^a   Belizaire, Roger ^b   Jenner, Peter ^c   Olanow, C Warren ^a   Isacson, Ole ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Synuclein; 26 20S proteasomes; Aggresome; Lactacystin; Lewy body inclusion; Parkin; Parkinson's disease; Ubiquitin C terminal hydrolase L1

Indexed keywords

PROTEASOME; CYSTEINE PROTEINASE; DOPAMINE; MULTIENZYME COMPLEX; PROTEIN SUBUNIT;

AGED; ALPHA CHAIN; ARTICLE; BETA CHAIN; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBUNIT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE CELL NECROSIS; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SUBSTANTIA NIGRA; WESTERN BLOTTING; ENZYMOLOGY; METABOLISM; NERVE CELL; PATHOLOGY;

AGED; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; DOPAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIENZYME COMPLEXES; NEURONS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; SUBSTANTIA NIGRA;

EID: 0037025111     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00296-3     Document Type: Article

References (20)

1. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
2. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion
3. Neuropathology of Parkinson's disease
4. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome
5. Understanding cell death in Parkinson's disease
6. The ubiquitin pathway in Parkinson's disease
7. Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation
8. Proteasomal function is impaired in substantia nigra in Parkinson's disease
9. Failure of the ubiquitin-proteasome system in Parkinson's disease
10. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures
11. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats
12. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
13. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells
14. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
15. Ubiquitination of a new form of {alpha}-synuclein by parkin from human brain: Implications for Parkinson's disease
16. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
17. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death
18. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
19. The 26S proteasome: A molecular machine designed for controlled proteolysis
20. Dynamic association of proteasomal machinery with the centrosome